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Abstract
Introduction. Bloodstream infections (BSI) are growing in incidence and present a serious health threat. Most patients wait up 
to 48 h before microbiological cultures can confirm a diagnosis. Low numbers of circulating bacteria in patients with BSI mean 
we need to develop new methods and optimize current methods to facilitate efficient recovery of bacteria from the blood-
stream. This will allow detection of positive blood cultures in a more clinically useful timeframe. Many bacterial blood recovery 
methods are available and usually include a combination of techniques such as centrifugation, filtration, serum separation or 
lysis treatment. Here, we evaluate nine different bacteria recovery methods performed directly from blood culture.
Aim. We sought to identify a bacterial recovery method that would allow for a cost- effective and efficient recovery of common 
BSI pathogens directly from blood culture.
Methods. Simulated E. coli ATCC 25922 blood culture was used as a model system to evaluate nine different bacteria recovery 
methods. Each method was assessed on recovery yield, cost, hands- on time, risk of contamination and ease of use. The highest 
scoring recovery method was further evaluated using simulated blood cultures spiked with seven of the most frequently occur-
ring bloodstream pathogens. The recovery yield was calculated based on c.f.u. count before and after each recovery method. 
Independent t- tests were performed to determine if the recovery methods evaluated were significantly different based on c.f.u. 
ml−1 log recovery.
Results. All nine methods evaluated successfully recovered E. coli ATCC 25922 from simulated blood cultures although the 
bacterial yield differed significantly. The MALDI- TOF intact cell method offered the poorest recovery with a mean loss of 
2.94±0.37 log c.f.u. ml−1. In contrast, a method developed by Bio- Rad achieved the greatest bacterial yield with a mean bacteria 
loss of 0.27±0.013 log c.f.u. ml−1. Overall, a low- speed serum- separation method was demonstrated to be the most efficient 
method in terms of time, cost and recovery efficiency and successfully recovered seven of the most frequent BSI pathogens 
with a mean bacteria loss of 0.717±0.18 log c.f.u. ml−1.
Conclusion. The efficiency of bacterial recovery can vary significantly between different methods and thereby can have a criti-
cal impact on downstream analysis. The low- speed serum- separation method offered a simple and effective means of recover-
ing common BSI pathogens from blood culture and will be further investigated for use in the rapid detection of bacteraemia and 
susceptibility testing in clinical practice.
InTRoduCTIon
Bacteria can invade and multiply in the normally sterile blood-
stream and this can have devastating clinical outcomes with 
bloodstream infections (BSI) associated with high mortality 
(20–46 %) and morbidity [1]. BSI caused by Gram- negative 
bacteria is of great concern with high rates of antimicrobial 
resistance [2–4]. E. coli is the most frequently isolated Gram- 
negative bacteria in BSI and is responsible for over 20 % of 
cases worldwide [5].
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Blood culture is the gold- standard for the diagnosis of BSI but 
is hindered by the long incubation time required to detect the 
very low circulating levels of bacteria (1–100 c.f.u. ml−1) [6–9]. 
After the detection of BSI an overnight culture is required for 
the identification (ID) of the causative pathogen and associ-
ated antimicrobial susceptibility (AST). Overall, this results 
in a delay in providing evidence- based treatment decisions 
by up to 48–72 h [10].
To optimize the workflow from patient to pathogen ID and 
AST, a variety of recovery methods have been developed for 
isolating bacteria directly from blood. Some of these recovery 
methods include mechanical filtration, centrifugation, sedi-
mentation, red blood cell lysis, chemical capture on surfaces 
or beads and microfluidic techniques [11–18]. Recovering 
bloodstream pathogens efficiently from the patient is vitally 
important in order to confidently rule in or rule out bacterial 
infection, to identify the causative agent and perform AST 
accurately and quickly. A method that enables bacterial ID 
and AST directly from positive blood culture would offer a 
significant reduction in turn- around time by removing the 
need for overnight culture.
In this study we evaluated a range of currently available 
blood- culture techniques for recovering E. coli directly from 
blood culture and examined the efficiency offered by each 
method. Other frequent BSI pathogens were used to further 
examine the influence of bacteria spp. on recovery efficiency.
METHodS
Bacteriological methods
Escherichia coli ATCC 25922 was used as a model organism 
to initially evaluate nine different recovery methods. The 
highest scoring recovery method was further evaluated by 
cultivating an additional six BSI pathogens, these were Staph-
ylococcus aureus ATCC 29213, Klebsiella pneumoniae ATCC 
700603, Pseudomonas aeruginosa ATCC 27853, Acinetobacter 
baumannii ATCC 19606, Streptococcus agalactiae ATCC 12386 
and Streptococcus pneumoniae ATCC 49619. ATCC reference 
strains were donated by Victoria Hospital, Kirkcaldy, UK and 
identified by Vitek 2. All strains were stored in glycerol stock 
at −80 °C until required. Cultures were grown from glycerol 
stock, by inoculating a 10 µl loopful of stock into 10 ml Brain- 
Heart Infusion (BHI) broth (Sigma Aldrich, UK). Cultures 
were incubated overnight at 37 °C in aerobic conditions (static 
incubation with lose cap) and each culture was grown to an 
optical density (OD600) of 0.6.
Preparation of surrogate blood culture
Blood culture refers to a blood sample inoculated into a 
rich broth media such as tryptic soy broth (TSB) to support 
optimal bacterial growth. A blood- to- broth ratio of between 
1 : 5 to 1 : 15 is required to remove the antibacterial effects of 
human blood [19–21]. A 1 : 10 blood- broth ratio was used in 
this study and this was consistent for all methods evaluated. 
Defibrinated horse blood (HB035, TCS Biosciences), TSB 
(Sigma Aldrich, UK) and a spiked concentration range of 102 
to 106 c.f.u. ml−1 E. coli ATCC 25922 was used to create a series 
of mock blood cultures to assess all nine recovery methods. 
Simulated blood cultures spiked with a bacterial concentra-
tion of 105 c.f.u. ml−1 were used to study recovery yield of all 
other BSI pathogens. The starting bacterial concentration in 
blood culture and the bacterial recovery yield was determined 
by c.f.u. using BHI plate counts based on the Miles and Misra 
method [22]. Colonies were counted at the highest dilution 
when visible in all three replicates after overnight incubation 
at 37 °C. Averages were taken and c.f.u. ml−1 were calculated.
Bacteriological recovery methods
Intact cell method
The intact cell method (ICM) for bacterial recovery was 
originally described by Ferreira and colleagues for performing 
direct bacterial identification from blood culture by matrix- 
assisted laser desorption ionization time- of- flight mass 
spectrometry (MALDI- TOF) [23]. Here, an adapted version 
of ICM was performed. A total of 4 ml of simulated blood 
culture was centrifuged at 2000 g for 30 s, the supernatant was 
centrifuged at 15 500 g for 5 min and the bacterial pellet was 
washed with 1 ml of deionized water for 15 s. The sample was 
centrifuged again at 15 000 g for 5 min and was re- suspended 
in 1 ml BHI broth. Aliquots were taken for dilution plates to 
assess bacterial recovery by change in c.f.u. ml−1.
Serum separation tube centrifugation
A protocol published by Barnini and colleagues was assessed 
[13]. An 8 ml portion of simulated blood culture was trans-
ferred into an 8.5 ml serum separator tube (SST) (Advanced 
SST Becton Dickson, UK). The sample was centrifuged at 
2000 g for 10 min and aliquots of the supernatant were used 
to perform a dilution plate to assess bacterial recovery. The 
protocol was repeated again, however the centrifugation 
step was changed to 1500 g for 10 min to assess the impact of 
centrifugation speed on bacterial recovery.
Lysis-filtration
Two in- house methods adapted from Fothergill and 
colleagues were developed to assess a combination of lysis 
and filtration in the recovery of bacteria directly from blood 
culture [14]. Protocol A involved treating a 9 ml simulated 
blood culture with 1 ml of 0.1 % Saponin (Alfa Aesar, UK) 
for 5 min. The resultant lysate was then filtered through 5 µM 
filter (Millipore, EMD, UK) and into a fresh 15 ml falcon tube. 
Protocol B involved osmotic lysis by diluting the simulated 
blood culture 1 : 100 in sterile deionized water. The resultant 
lysate was then passed through a 5 µM filter. Aliquots of the 
resultant lysate were taken to assess recovery yield by dilution 
plate (c.f.u. ml−1).
Lysis-centrifugation
A method reported by Lupetti and colleagues was evalu-
ated [24]. A 7 ml portion of a simulated blood culture was 
treated with 0.01 % Saponin for 15 min at room temperature. 
The sample was then transferred to a SST and underwent 
centrifugation at either 1500 g or 2000 g for 10 min. Aliquots 
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of the supernatant were serially diluted and used to perform a 
series of dilution plates to determine bacterial recovery yield 
(c.f.u. ml−1).
Bio-Rad β LACTA test protocols A and B
Both methods were performed in accordance with the manu-
facturer’s instructions (Bio- Rad, Marnes- la- Coquette, France) 
[25]. For protocol A, 2 ml of simulated blood culture was trans-
ferred into an 8.5 ml SST and centrifuged at 2000 g for 10 min. 
The supernatant was removed and the sediment of bacteria 
present on the gel was washed in 1 ml sterile water. The sample 
was centrifuged at 300 g for 3 min and 800 µl of the sample 
was transferred into a microcentrifuge tube. Centrifugation 
at 15 000 g for 1 min allowed a bacterial pellet to be obtained 
and this was re- suspended in 1 ml of BHI media. For protocol 
B, an aliquot of 1 ml of blood culture underwent centrifuga-
tion at 1000 g for 1 min. The supernatant was discarded and 
the remaining pellet was treated with Triton X-100 solution 
at 0.1 % and mixed for 10 s by vortexing. A second centrifu-
gation of 13 000 g for 1 min allowed a bacterial pellet to be 
obtained. The bacteria were re- suspended and washed with 
1 ml of sterile deionized water. Centrifugation at 13 000 g for 
1 min allowed the bacterial pellet to be re- suspended in 1 ml 
of BHI media. Aliquots of bacterial re- suspensions were used 
to perform a dilution plate and to calculate bacterial recovery 
yield (c.f.u. ml−1).
data analysis
Bacteria recovery yield was the calculated log difference 
between the expected and observed c.f.u. plate count, each 
method was performed in triplicate and is expressed as 
mean±sem. Independent t- tests were used to determine if 
a statistically significant difference was present between 
different recovery methods and recovery yield. P<0.05 was 
considered significant.
All data analysis was performed using GraphPad Prism 7.04.
RESuLTS
Evaluation of E. coli ATCC 25922 recovery yield by 
method comparison
Comparison of all nine methods showed each method to 
recover E. coli successfully (Fig. 1). However, the recovery 
yield obtained across the different methods was significantly 
different ranging from a log c.f.u. ml−1 loss of 0.26 to 2.94 
bacteria (P<0.005). The intact cell method had the poorest 
bacterial yield from blood culture and was significantly 
different from all other methods tested (P<0.01). In contrast, 
Bio- Rad protocol B was observed to have the greatest 
recovery yield with only a small change between the spiked 
and recovered bacterial concentration (see Fig. 1g). Other 
methods such as serum separation by SST centrifugation was 
optimal at the lower centrifugation speed of 1500 g compared 
to 2000 g offering good recovery yields of less than one log 
c.f.u. ml−1 loss (P=0.001). The addition of a lysis pre- treatment 
with 0.1 % saponin before SST centrifugation at 2000 g signifi-
cantly enhanced recovery to less than 0.5 log c.f.u. ml−1 loss 
(P=0.001). However, pre- treatment with 0.1 % saponin did not 
significantly enhance recovery at 1500 g SST centrifugation. 
Alternatively, the two lysis- filtration- based methods tested 
were not significantly different with a bacteria reduction of 
0.4–1 log c.f.u. ml−1.
In addition to evaluating the bacterial recovery yield offered 
by each recovery method it was also equally important to 
consider the impact on cost- effectiveness and the time 
involved in performing each method. Table 1 summarizes all 
of these aspects for all nine methods.
Table 1 shows the recovery yield varied significantly with each 
method ranging from a log loss of 0.07 to 3.45 bacteria. The 
hands- on time and turnaround- time per method ranged from 
5 to 25 min and 15–30 min, respectively. All methods evalu-
ated were inexpensive ranging from £0.069–£2.86. *The mean 
log c.f.u. change was calculated over a concentration gradient 
of 102 to 106 c.f.u. ml−1.
The recovery yield of seven common BSI pathogens 
using low speed serum separation
The low- speed serum- separation (LS- SST) method achieved 
the best combination of good recovery yield with low cost 
and quick preparation time. The study, therefore, evalu-
ated the LS- SST method for the direct recovery of the most 
common BSI pathogens from simulated blood culture. 
Fig. 1. Comparison of bacteria yield from blood culture. Centrifugation- 
based methods included (a) the intact cell method (3.45±0.22 to 
2.04±0.05 log c.f.u. ml−1), (b and c) SST centrifugation at two different 
centrifugation speeds (2000 g 1.14±0.56 to 2.29±0.54 log c.f.u ml−1 
and 1500 g 0.29±0.02 to 0.91±0.14 log c.f.u. ml−1), (d and e) SST 
centrifugation with saponin (2000 g 0.32±0.45 to 0.60±0.40 log c.f.u. 
ml−1 and 1500 g 0.07±0.27 to 0.54±0.33 log c.f.u. ml−1),(f and g) Bio- 
Rad PR A and PR B (PRA 0.65±0.10 to 1.36±0.17 log c.f.u.ml−1 and PR 
B 0.22±0.11 to 0.27±0.089 log c.f.u. ml−1). Filtration- based methods for 
bacterial recovery from blood culture included (h) Lysis by osmosis 
and 5 µM filtration (0.41±0.67 to 1.08±0.07 log c.f.u. ml−1) and (i) lysis by 
0.01 % saponin and 5 µM filtration (0.73±0.03 to 1.12±0.32 log c.f.u. ml−1).
809
Falconer et al., Journal of Medical Microbiology 2020;69:806–811
Fig. 2 demonstrates that the LS- SST method facilitated the 
successful recovery of all seven BSI pathogens from blood 
culture. However, the recovery yield of bacteria was statisti-
cally significantly different among BSI pathogens and ranged 
from 0.21 to 1.74 c.f.u. ml−1 log loss (P<0.05). K. pneumoniae 
and E. coli presented with the highest recovery rates with 
S. aureus presenting with the lowest recovery of all the patho-
gens tested.
dISCuSSIon
Early detection of bacteraemia has been shown to signifi-
cantly improve patient care [1]. One way of improving the 
time to detection is to perform analysis directly from blood 
cultures, which potentially could save up to 24 h [26, 27]. 
This is one of few studies that has investigated and quantified 
the bacterial loss associated with extracting bacteria directly 
from positive blood cultures [28–33]. Recovery efficiency was 
evaluated for each of the nine methods by quantifying the 
recovery yield by colony plate counts (c.f.u. ml−1). E. coli was 
selected as a model organism to initially screen for the best 
recovery method – a predominant BSI pathogen accountable 
for up to 20–30 % of BSI cases [5, 34]. Here, we focussed on 
methods that would offer a rapid, cost- effective and transfer-
able solution for extracting bacteria from blood culture in a 
low- cost and high throughput setting.
Ideally, a simple protocol with minimal steps is required in 
order to process blood cultures quickly; minimize the risk of 
contamination and reduce bacterial loss due to transfer. The 
hands- on time for the methods included in the study ranged 
from 5 to 25 min and the number of steps involved ranged 
from 3 to 10. A protocol from Bio- Rad provided the highest 
efficiency. The Bio- Rad protocol involves seven steps in total 
including three centrifugation steps, one lysis treatment and 
one washing step, with a total process time of 30 min. The 
scalability and time required to perform this method may 
make it less favourable in a high- throughput environment. 
Nevertheless, the most advantageous aspect of this approach 
is the high bacterial yield obtained. The ability to support the 
recovery of the very low bacteria counts commonly isolated 
from bacteraemia patients will enable improvement in time to 
detection where the starting concentration of blood culture is 
directly linked to time to positive ID and detection of antimi-
crobial resistance [35]. This is of high importance especially in 
low- volume blood samples or when a slow- growing pathogen 
is suspected of causing bacteraemia, both of which require 
a long incubation time and can take up to 5 days to become 
detectable on current blood- culture detection platforms [36].
Filtered- based methods have been shown to offer good bacte-
rial recovery rates in this study and in previous studies [11]. 
Nonetheless, filtration- based methods may not be applicable 
for processing a large number of samples with greater tech-
nicality and more time required per sample, which in turn 
heightens the risk of contamination. Another consideration is 
the blood sample must be diluted to avoid a blood- filter cake 
forming, which may present an issue for low concentration 
and low- volume samples, for example in paediatrics [37]. 
Additionally, filtered- based methods were around nine times 
more expensive for each sample compared to centrifugation- 
based methods evaluated. The opportunity for automation 
using filtered- based methods is currently limited, which 
Table 1. Evaluation of nine different recovery methods direct from 
blood culture
Recovery method Recovery rate
(mean c.f.u. 
log change*)
Hands- on 
time/total time
Cost per 
sample
Ref.
Serum separation 
(2000 g)
1.14–2.29 5 min/15 min £0.37 [13]
Serum separation 
(1500 g)
0.29–0.91 5 min/15 min £0.37 [13]
Bio- Rad recovery 
protocol A
0.65–1.36 25 min/30 min £0.42 [25]
Bio- Rad recovery 
protocol B
0.22–0.27 25 min/30 min £0.19 [25]
Serum 
separation+chemical 
lysis (2000 g)
0.32–0.60 5 min/20 min £0.38 [24]
Serum 
separation+chemical 
lysis (1500 g)
0.07–0.54 5 min/20 min £0.38 [24]
Chemical lysis and 
filtration
0.73–1.12 20 min/25 min £2.86 [14]
Natural lysis and 
filtration
0.44–1.08 10 min/15 min £2.86 [14]
MALDI- TOF (intact 
cell method)
2.04–3.45 25 min/30 min £0.069 [23]
Fig. 2. Recovery comparison of the most frequently associated BSI 
pathogens using SST centrifugation (1500 g). The LS- SST method 
successfully recovered 7/7 BSI pathogens from simulated blood 
culture spiked at 105 c.f.u. ml−1. The mean bacterial log reduction across 
BSI pathogens was 0.717±0.18 log c.f.u. ml−1 (P<0.05).
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may present a challenge in streamlining this method into the 
workflow of some laboratories.
Most promising was the adapted SST method that offered a 
high recovery yield in a two- step process and further inves-
tigation demonstrated the LS- SST method to provide high 
recovery rates for seven common BSI pathogens with as little 
as 5 min hands- on time. SST offers a simple way to remove the 
high concentrate of haemocytes from the sample while leaving 
the bacteria intact in the serum. The removal of haemocytes 
from the sample is imperative for bacterial growth with the 
antibacterial effects of blood long been recognized [38]. Addi-
tionally, the purity of the bacteria extract will influence the 
accuracy and detection of molecular and phenotypic assays 
[39]. Barnini and colleagues have importantly demonstrated a 
SST method to facilitate rapid AST direct from blood culture 
in 6 h and due to the simplicity of approach and low- cost, this 
method can be applied and used to support many other direct 
and rapid bacteria ID and AST technologies [13].
E. coli was used as a model organism to screen numerous 
methods, followed by a full evaluation of the overall best 
method against the most common BSI pathogens. These 
include A. baumannii, K. pneumoniae, P. aeruginosa, 
S. agalactiae, S. aureus and S. pneumoniae, which are collec-
tively responsible for 60.5 % of BSI cases worldwide [5]. This 
allowed the effective study of numerous recovery methods 
and the variation of recovery efficiencies amongst bacteria 
spp. Notably, S. aureus and other Gram- positive bacteria had 
lower recovery efficiencies in comparison to Gram- negative 
bacteria. Determining recovery efficiencies by c.f.u. ml−1 may 
have underestimated the true size of the active bacterial popu-
lation in the case of Gram- positive bacteria. Gram- positive 
bacteria tend to aggregate and grow in grape- like clusters 
(cell- masses) or typical arrangements (chains) compared to 
Gram- negative bacteria that tend to grow as single rods [40]. 
This difference in growth characteristics and typical bacte-
rial arrangement between Gram- positive and Gram- negative 
bacteria may also be attributed to method- specific differences. 
For example, the clustering and surface adherence of S. aureus 
may have reduced the ability to recover these bacteria when 
using the selected SST method. This highlights that one 
recovery method for all BSI pathogens may not be the optimal 
approach. Instead further screening using a Gram- positive 
organism such as S. aureus may favour an alternative recovery 
method and may be valuable in recovering Gram- positive 
bacteria directly from blood. However, the high bacterial load 
of blood culture, normally in excess of 108 c.f.u. ml-1, means 
the variation in recovery efficiencies observed across bacteria 
spp. using the SST approach is unlikely to compromise BSI 
coverage or rapid downstream analysis with a standardized 
AST concentration of 105 c.f.u. ml−1 [41].
The use of horse blood offered a good surrogate to evaluate a 
number of different bacterial recovery methods without the 
need to involve human participants. Although, horse blood 
and human blood share a similar packed cell volume (PCV) 
of between 40–50 %, horse blood contains a much higher 
concentration range of erythrocytes than human blood, 
6.0–9.6×1012 l−1 and 3.5–5.9×1012 l−1, respectively [42, 43]. As 
the exact erythrocyte concentration could not be quantified 
in the study, it is difficult to assess the impact a higher eryth-
rocyte concentration may have had on bacterial recovery.
Another consideration is that clinically positive blood 
cultures are likely to contain bacteria that have undergone 
stress either as a result of an immune challenge or in some 
cases pre- exposure to antimicrobials. Clinical blood cultures 
may also be polymicrobial, containing more than one bacte-
rial spp. and this occurs in around 11.6 % of BSI cases [44]. 
It is important to note that the recovery efficiencies given 
in this study are reflective of monomicrobial cultures only. 
The effect of bacterial stress and polymicrobial growth on 
bacterial recovery among patient blood cultures remains to 
be explored through future clinical studies.
Direct processing of blood culture for ID and AST is the 
way forward in cutting time to inform treatment decisions 
in bacteraemia. The recovery of bacteria from blood culture 
influences the quality and efficiency of the downstream 
analysis and therefore the recovery method must be carefully 
selected. Here, we have presented the efficiencies of common 
recovery methods, addressing a deficiency in the literature. 
Importantly, some ID and AST methods may perform better 
with different recovery methods. For instance, rapid molec-
ular ID and AST methods would be optimal using a recovery 
method that enables complete removal of human cells and 
other PCR inhibitors. Other methods that detect ID and AST 
phenotypically are impacted not so much by the presence of 
human cells but the starting bacterial concentration. Based on 
the objectives of the study, the SST method was the optimal 
recovery method and will be further tested in combination 
with a rapid phenotypic detection and rapid AST system.
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